Olopatadine Hydrochloride 73581-0709
Product NDC
73581-0709- Manufacturer
- Yyba Corp
- Dosage Form
- Solution
- Route
- Ophthalmic
- Product Type
- Human Otc Drug
- Marketing Start
- March 1, 2026
- Listing Expires
- December 31, 2027
- Application
- ANDA219557
Active Ingredients
| Ingredient | Strength |
|---|---|
| Olopatadine Hydrochloride | 2 mg/mL |
Drug Class
Decreased Histamine Release [PE]Histamine H1 Receptor Antagonists [MoA]Histamine-1 Receptor Antagonist [EPC]
Packaging Options(1)
2 BOTTLE in 1 CARTON (73581-709-02) / 2.5 mL in 1 BOTTLE